Cancers: up to 42 per cent are diagnosed in A&E: a focus on the lungs, stomach and intestines, and the brain
Transforming the first point of contact at hospital from a random stop-off into an early detection point and eliminating delays in care: an initiative by experts in emergency medicine and oncology
Key points
A project to transform the A&E department into a structured point for the early detection of suspected cancer, with two objectives: to fill the knowledge gap regarding the true scale of cancer diagnoses made in A&E departments in Italia – where data is lacking – and to standardise the management of cancer patients in emergency departments. It has been named ‘Hopes – Harnessing Oncology Pathways in Emergency Settings’ and is being developed under the scientific guidance of AIOM (Italian Association of Medical Oncology) and SIMEU (Italian Society of Emergency and Urgent Medicine), with methodological coordination by Helaglobe.
International data
This situation certainly warrants further investigation in our country, with a view to improving our ability to identify and manage patients: between 24 per cent and 42.5 per cent of cancer diagnoses are made within 30 days of an emergency admission, according to a study by the International Cancer Benchmarking Partnership, which analysed over 850,000 cases across 14 geographical areas; the study found that those diagnosed in A&E also have a higher one-year mortality rate. In Italia, however, as mentioned, this data does not exist: there are no national registers measuring how many cancer diagnoses are made in A&E, nor are there any indicators on the time taken to take patients into care or on outcomes.
A “no-man’s-land” A&E department
In cancer care, the A&E department is currently an ‘unregulated link’. Over the past twenty years, cancer networks have developed increasingly complex specialist care pathways, but those who arrive via A&E are often excluded from them. Frequently, when a cancer is discovered in A&E, it is because the warning signs from the preceding months were not picked up in time. The diagnosis therefore comes at the most critical moment, when a more advanced disease, a more compromised general condition and the need to commence treatment under significant organisational pressure all converge. And time is of the essence: a four-week delay in starting treatment increases the risk of death from 6 per cent to 28 per cent depending on the treatment, with figures around 6–8 per cent for surgery.
What do we know in Italia
The limited data available, which is restricted to individual areas, suggests that the phenomenon is significant. In the provinces of Milan and Lodi, out of over 10,000 cases of colon cancer diagnosed between 2014 and 2020, 35.6 per cent were detected following presentation to A&E, compared with 8.4 per cent identified through screening. Diagnosis in A&E was associated with higher mortality rates at both 30 days and one year. In Parma, over a ten-year period, 205 adults were identified with a first diagnosis of brain cancer made in A&E. Furthermore, this phenomenon does not affect everyone in the same way. Advanced age, financial difficulties, mental health conditions and substance use increase the likelihood of a tumour being detected in A&E. In the Milan area, amongst people with a pre-existing mental health condition, the proportion rises to 43.8 per cent, compared with 33.8 per cent of other patients.
Aggressive disease or delayed diagnosis?
“HOPES was set up to fill a knowledge gap that could no longer be sustained: our primary objective is to measure cancer diagnoses in A&E settings on a national scale,” explains Fabio De Iaco, Director of Emergency and Urgent Care Medicine at the Maria Vittoria Hospital in Turin and Past President of Simeu. With HOPES, we aim to map the patient’s journey from arrival at A&E to the start of treatment, beginning with three groups of cancers that frequently present in the emergency department: lung, gastrointestinal tract and central nervous system. Not every diagnosis in the emergency department is a missed opportunity: we must distinguish between cases where admission is unavoidable due to the aggressiveness of the tumour and those linked to delays in care. But it is in the post-admission pathway that a breakthrough is needed. Today – the specialist continues – A&E and Oncology coexist within the same facilities, but there is a lack of standardised interdisciplinary dialogue. Hopes’ aim is to build a reliable picture of the situation, from which to define shared pathways so that suspected cancer is recognised in time and the patient is guided, without interruption, from A&E through to oncology; thereby avoiding unnecessary hospital admissions solely for the purpose of reaching a diagnosis and making better use of the National Health Service’s resources’.

